IMMUNOSUPPRESSION
Clinical trials for IMMUNOSUPPRESSION explained in plain language.
Never miss a new study
Get alerted when new IMMUNOSUPPRESSION trials appear
Sign up with your email to follow new studies for IMMUNOSUPPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to save sepsis patients by restoring immune function
Disease control Not yet recruitingThis study tests whether adding an experimental drug (NAI) to standard care can help critically ill sepsis patients with persistently low lymphocyte counts (a sign of immune weakness) survive longer. About 50 adults in the ICU will be randomly assigned to receive either NAI injec…
Matched conditions: IMMUNOSUPPRESSION
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
New drug aims to stop kidney rejection in small trial
Disease control Not yet recruitingThis study tests a new medicine called TNX-1500 in 5 people who get a kidney transplant. The goal is to see if it is safe and helps prevent the body from rejecting the new kidney. Participants will be followed for one year to check for side effects and signs of rejection.
Matched conditions: IMMUNOSUPPRESSION
Phase: PHASE2 • Sponsor: Ayman Al Jurdi, MD • Aim: Disease control
Last updated May 22, 2026 13:51 UTC